Going forward in Europe, while we expect further improvement to our performance in the marketplace and across geographies, we expect Q2 organic top line and EBITDA to be held back by two factors: one, is shipments phasing versus the prior year where some July shipments were pulled into June last year; the second is the likelihood of unfavorable product costs as we will continue to face transactional foreign exchange headwinds within our supply chain in the near-term